*McGill University, Montreal, Quebec, Canada; †Institute of Mental Health Research, University of Ottawa, Ottawa, Ontario, Canada; ‡Department of Psychiatry, Notre-Dame Hospital, University of Montreal, Montreal, Quebec, Canada; §University of British Columbia, Vancouver, BC, Canada; ∥Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada; ¶Pfizer Inc, New York, USA; and #Pfizer Canada, Montreal, Quebec, Canada
Received August 3, 2001; accepted after revision December 28, 2001.
Funded by Pfizer Canada, Inc.
Address reprint requests to: A.V. Ravindran, MD, PhD, FRCP(C), Institute of Mental Health Research, University of Ottawa, 1145 Carling Avenue, Ottawa, Ontario, Canada K1Z 7K4.